Importance of attributable risk in monitoring adverse events after immunization: Hepatitis B vaccination in children

American Journal of Public Health

Volumn 91, Issue 2, 2001, Pages 313-315

  De Serres, G ^a   Duval, B ^a   Boulianne, N ^a   Rochette, M ^a   Dionne, M ^a   Fradet, M D ^a   Masse R ^a  

^a Public Health Research Unit   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; CHILD CARE; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MALE; RISK ASSESSMENT; SCHOOL CHILD;

EID: 0035150444     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.91.2.313     Document Type: Article

References (7)

1. Casualty and evidence
2. Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children
3. Summary of clinical findings on Engerix-B, a genetically engineered yeast-derived hepatitis B vaccine
4. Special methodological issues in pharmacoepidemiology: Studies of vaccine safety